Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.

ABSTRACT:

Background

Growing numbers of people are using psychedelics for personal psychotherapy outside clinical settings, but research on such use is scarce.

Aims

This study investigated the patterns of use, self-reported outcomes and outcome predictors of psychedelic 'self-treatment' of mental health conditions or specific worries/concerns in life.

Methods

We use data from the Global Drug Survey 2020, a large online survey on drug use collected between November 2019 and February 2020. In all, 3364 respondents reported their self-treatment experiences with lysergic acid diethylamide (N = 1996) or psilocybin mushrooms (N = 1368). The primary outcome of interest was the 17-item self-treatment outcome scale, items reflecting aspects of well-being, psychiatric sympt

SUBMITTER: Kopra EI 

PROVIDER: S-EPMC10350727 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature